Evidence map›Paper›PMID 34764478›Full record

ArticleNature2021

Author Correction: Codon-specific translation reprogramming promotes resistance to targeted therapy.

Francesca Rapino, Sylvain Delaunay, Florian Rambow, Zhaoli Zhou, Lars Tharun, Pascal De Tullio, Olga Sin, Kateryna Shostak, Sebastian Schmitz, Jolanda Piepers and 19 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Francesca RapinoLaboratory of Cancer Signaling, University of Liège, Liège, Belgium.
Sylvain DelaunayLaboratory of Cancer Signaling, University of Liège, Liège, Belgium.
Florian RambowLaboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
Zhaoli ZhouLaboratory of Cancer Signaling, University of Liège, Liège, Belgium.
Lars TharunInstitute for Pathology, University Hospital Cologne, Cologne, Germany.
Pascal De TullioCentre for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium.
Olga SinMax Planck Research Group for RNA Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Kateryna ShostakGIGA-institute, University of Liège, Liège, Belgium.
Sebastian SchmitzLaboratory of Cancer Signaling, University of Liège, Liège, Belgium.
Jolanda PiepersDepartment of Radiotherapy (MAASTRO)/GROW, School for Developmental Biology and Oncology, Maastricht University, Maastricht, The Netherlands.
Bart GhesquièreMetabolomics Core Facility, Center for Cancer Biology, VIB, Leuven, Belgium.
Latifa KarimGIGA-institute, University of Liège, Liège, Belgium.
Benoit CharloteauxGIGA-institute, University of Liège, Liège, Belgium.
Diane JamartLaboratory of Cancer Signaling, University of Liège, Liège, Belgium.
Alexandra FlorinInstitute for Pathology, University Hospital Cologne, Cologne, Germany.
Charles LambertGIGA-institute, University of Liège, Liège, Belgium.
Andrée RoriveMedical Oncology, CHU Sart Tilman Liège, University of Liège, Liège, Belgium.
Guy JerusalemMedical Oncology, CHU Sart Tilman Liège, University of Liège, Liège, Belgium.
Eleonora LeucciLaboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
Michael DewaeleLaboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
Marc VooijsDepartment of Radiotherapy (MAASTRO)/GROW, School for Developmental Biology and Oncology, Maastricht University, Maastricht, The Netherlands.
Sebastian A LeidelMax Planck Research Group for RNA Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Michel GeorgesGIGA-institute, University of Liège, Liège, Belgium.
Marianne VozGIGA-institute, University of Liège, Liège, Belgium.
Bernard PeersGIGA-institute, University of Liège, Liège, Belgium.
Reinhard BüttnerInstitute for Pathology, University Hospital Cologne, Cologne, Germany.
Jean-Christophe MarineLaboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
Alain ChariotGIGA-institute, University of Liège, Liège, Belgium.
Pierre CloseLaboratory of Cancer Signaling, University of Liège, Liège, Belgium. Pierre.Close@uliege.be.ORCID http://orcid.org/0000-0002-8844-9616

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34764478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.